Nick Klenske

According to the CDC, cigarette smoking is responsible for as much as 90% of lung cancer deaths in the U.S. As such, it should come as no surprise that the best way to prevent lung cancer is to not smoke or, if you do, to quit. But what about the use of e-cigarettes, or vaping — particularly by former smokers?

According to a recent European Radiology study, the use of short-protocol brain MRI on emergency patients with inconclusive neurological symptoms is a cost-effective method for detecting minor strokes.

The use of e-cigarettes, also known as vaping, has risen over the past decade. In 2019, an illness linked to vaping was discovered following an outbreak of unexplained respiratory illnesses in Wisconsin. According to a Chest Journal study, vaping induced lung injury, which came to be known as e-cigarette or vaping-induced lung injury (EVALI), hospitalized 2,807 and killed 68 people between March 2019 and February 2020.

New research shows the important role mathematical modelling tools can play in understanding how COVID-19 spreads – and mitigating its effects.

Since 2004, the CT Clinical Innovation Center (CT CIC) has been integrating clinical practice and innovation with research on a day-to-day basis.

In the summer of 2020, the ongoing COVID-19 pandemic and multiple incidents of police brutality against African Americans converged to shift the national narrative on racial justice. Included in this conversation was a new look at how health care disparities based on race and ethnicity affect population health.

It’s been said that cybersecurity represents the greatest threat to every sector in the world — and radiology is no exception. Yet most of us probably don’t give it a second thought, seeing it as a problem for multinational companies or an issue for the IT department to take care of. But this is a dangerous misconception.

Health disparities based on race and ethnicity are both widespread and pervasive — and radiology is no exception.

Imaging’s role in cancer diagnosis and treatment continues to grow in importance. At the forefront of this development is interventional oncology (IO), a rapidly expanding subspecialty of interventional radiology.

A method called induced pluripotent stem cells could be the key to a future of safer chemicals without the need for toxicity testing in animals.

Research into the cortical reorganisation that happens after a spinal cord injury could open the door to new treatments.

Despite the now sizeable number of reports on the use of AI to aid breast cancer screening, most studies are either standalone and/or retrospective in nature. As such, their current bearing on AI’s role in the clinical setting seems limited.

By redefining breast cancer as a heterogeneous group of 11 different diseases, researchers aim to significantly advance our understanding of tumour biology – and our ability to treat the condition.

More and more people are at risk of developing age-related eye diseases that could cause blindness. The key to treating and managing such diseases is to understand the risk factors involved. To help, one EU-funded project has developed tools that predict not only how likely a person is to develop eye diseases but also what can be done to lower this risk.

Intrapartum antimicrobial prophylaxis (IAP), is a standard procedure used while delivering babies. According to EU-funded researchers, it may have important implications for infant health, increasing risks of obesity, diabetes, and antibiotics resistance. This finding opens the door to the development of new dietary strategies for minimising the effect of this very common medical procedure.